Mass Spectrometric Method for Determining the Uronic Acid Epimerization in Heparan Sulfate Disaccharides Generated Using Nitrous Acid
Affiliations
Heparan sulfate (HS) glycosaminoglycans (GAGs) regulate a host of biological functions. To better understand their biological roles, it is necessary to gain understanding about the structure of HS, which requires identification of the sulfation pattern as well as the uronic acid epimerization. In order to model HS structure, it is necessary to quantitatively profile depolymerization products. To date, liquid chromatography-mass spectrometry (LC-MS) methods for profiling heparin lyase decomposition products have been shown. These enzymes, however, destroy information about uronic acid epimerization. Deaminative cleavage using nitrous acid (HONO) is a classic method for GAG depolymerization that retains uronic acid epimerization. Several chromatographic methods have been used for analysis of deaminative cleavage products. The chromatographic methods have the disadvantage that there is no direct readout on the structures producing the observed peaks. This report demonstrates a porous graphitized carbon (PGC)-MS method for the quantification of HONO generated disaccharides to obtain information about the sulfation pattern and uronic acid epimerization. Here, we demonstrate the separation and identification of uronic acid epimers as well as geometric sulfation isomers. The results are comparable to those expected for benchmark HS and heparin samples. The data demonstrate the utility of PGC-MS for quantification of HS nitrous acid depolymerization products for structural analysis of HS and heparin.
High-throughput glycosaminoglycan extraction and UHPLC-MS/MS quantification in human biofluids.
Volpi N, Galeotti F, Gatto F Nat Protoc. 2024; .
PMID: 39543382 DOI: 10.1038/s41596-024-01078-9.
Rodrigues T, Cunha R, Barci P, Santos-Neto A, Lancas F Anal Bioanal Chem. 2024; 416(24):5233-5253.
PMID: 39158631 DOI: 10.1007/s00216-024-05458-8.
Influence of saccharide modifications on heparin lyase III substrate specificities.
Wu J, Chopra P, Boons G, Zaia J Glycobiology. 2021; 32(3):208-217.
PMID: 33822051 PMC: 8966481. DOI: 10.1093/glycob/cwab023.
Discovery of exolytic heparinases and their catalytic mechanism and potential application.
Zhang Q, Cao H, Wei L, Lu D, Du M, Yuan M Nat Commun. 2021; 12(1):1263.
PMID: 33627653 PMC: 7904915. DOI: 10.1038/s41467-021-21441-8.
Trabszo C, Ramms B, Chopra P, Lullmann-Rauch R, Stroobants S, Spross J Biochem J. 2020; 477(17):3433-3451.
PMID: 32856704 PMC: 8261863. DOI: 10.1042/BCJ20200546.